Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ZYME — Zymeworks Inc.

CIK 1214717 BOSTON, MA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$18,099,596
+$1,574,699 QoQ
Shares Held
692,410
+4.9% QoQ
Ownership
0.976%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 202 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ZYME ranks #146 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ZYME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,099,596 692,410
2026-03-31 $16,524,897 659,940
2025-12-31 $17,061,049 647,970
2025-09-30 $11,591,102 678,636
2025-06-30 $8,852,317 705,364
2025-03-31 $8,396,966 705,035
2024-12-31 $10,099,901 689,884
2024-09-30 $8,959,632 713,915
2024-06-30 $6,067,203 712,950
2024-03-31 $7,037,711 668,984
2023-12-31 $6,646,192 639,672
2023-09-30 $3,800,595 599,463
2023-06-30 $4,855,049 561,927
2023-03-31 $284,760 31,500